Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

China ,California ,United States ,San Diego ,Japan ,Deepankar Roy ,Linkedin ,Ultragenyx Pharmaceutical Inc ,Company Board Of Directors ,Twitter ,Janssen Pharmaceuticals Inc ,Arcturus Therapeutics Holdings Inc ,Cystic Fibrosis Foundation ,Janssen Pharmaceutical Companies Of Johnson ,Nasdaq ,Takeda Pharmaceutical Company ,Mrna Technology ,Therapeutics Holdings ,Compensation Committee ,Nasdaq Rule ,Arcturus Therapeutics Holdings ,Janssen Pharmaceuticals ,Janssen Pharmaceutical Companies ,Ultragenyx Pharmaceutical ,Takeda Pharmaceutical Company Limited ,Cystic Fibrosis ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Public Relations ,Business Wire ,Coronavirus Pandemic ,Technology ,Health ,Business ,Infectious Diseases ,